The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder characterized by incompletely reversible airflow obstruction. Bacterial infection of the lower respiratory tract contributes to approximately 50% of COPD exacerbations. Even during periods of stable lung function, the lung harbors a community of bacteria, termed the microbiome. The role of the lung microbiome in the pathogenesis of COPD remains unknown. The COPD lung microbiome, like the healthy lung microbiome, appears to reflect microaspiration of oral microflora. Here we describe the COPD lung microbiome of 22 patients with Moderate or Severe COPD compared to 10 healthy control patients. The composition of the lung microbiomes was determined using 454 pyrosequencing of 16S rDNA found in bronchoalveolar lavage fluid. Sequences were analyzed using mothur, Ribosomal Database Project, Fast UniFrac, and Metastats. Our results showed a significant increase in microbial diversity with the development of COPD. The main phyla in all samples were Actinobacteria, Firmicutes, and Proteobacteria. Principal coordinate analyses demonstrated separation of control and COPD samples, but samples did not cluster based on disease severity. However, samples did cluster based on the use of inhaled corticosteroids and inhaled bronchodilators. Metastats analyses demonstrated an increased abundance of several oral bacteria in COPD samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The microbiome, including the mycobiome, is largely dependent on the area of the body, and may be altered during disease (Pragman et al., 2010; Mukherjee et al., 2014; Gouba and Drancourt, 2015).”
From Iron at the Centre of Candida albicans Interactions (2018) · cites this paper as Pragman et al., 2010
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549 · cited 1×
“uchime implemented in mothur [37] were used to truncate low-quality sequences and remove chimeras, respectively.”
MethodMuyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,429 · cited 1×
“PCR amplification using 16S rRNA gene primers specific to the constant regions flanking the V3 region [35,36] was performed using 20 cycles.”
MethodMultiple sequence alignment with the Clustal series of programs
Chenna, R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg500 · Cited by 4,875 · cited 1×
“For PCoA analyses, sequences were dereplicated and ClustalW was used to align the dereplicated sequences [38].”
MethodThe Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762 · cited 2×
“To minimize effects of random sequencing errors, we used RDP Pipeline [4] to eliminate (a) sequences that did not appropriately match the PCR primer and the barcode at the beginning of a read, (b) sequence reads with ,50 bases after the proximal PCR primer if they terminated before reaching the distal”
MethodDewhirst, F. E., Chen, T., Izard, J., Paster, B. J., Tanner, A. C. R., Yu, W.-H., Lakshmanan, A., & Wade, W. G. (2010) · Journal of Bacteriology · doi:10.1128/jb.00542-10 · Cited by 3,352
Disordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., Pachter, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,824 · cited 1×
“The microbiome in early childhood may play a role in the development of asthma [8], while specific components of the microbiome are associated with chronic asthma in adulthood [9].”
BackgroundImproved extraction of PCR-quality community DNA from digesta and fecal samples
Yu, Z., & Morrison, M. (2004) · BioTechniques · doi:10.2144/04365st04 · Cited by 1,664 · cited 1×
“We used a previously described protocol [33] for DNA isolation that included bead beating to lyse bacterial cells, followed by precipitation with isopropanol and digestion with RNase.”
MethodStatistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,586 · cited 1×
“Metastats [40] was used to detect differentially abundant taxa using taxonomic data from RDP Classifier controlling the false discovery rate at 10% for each level of the taxonomy.”
MethodMicrobiota regulates immune defense against respiratory tract influenza A virus infection
Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019378108 · Cited by 1,502 · cited 1×
“showed that the mouse microbiome helps regulate the immune function necessary to respond to Influenza A virus infection [12].”
BackgroundTopographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract
Charlson, E. S., Bittinger, K., Haas, A. R., Fitzgerald, A. S., Frank, I., Yadav, A., Bushman, F. D., & Collman, R. G. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0655oc · Cited by 1,144 · cited 4×
“[7] who noted that the bacteria in the BALF arise from upper respiratory tract bacteria, likely through a combination of microaspiration and bronchoscopic carryover during sampling.”
BackgroundInfluential
Cited by
Schwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
Emerging Pathogenic Links Between Microbiota and the Gut-Lung Axis
Budden, K. F., Gellatly, S. L., Wood, D. L. A., Cooper, M. A., Morrison, M., Hugenholtz, P., & Hansbro, P. M. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.142 · Cited by 1,606
Proteobacteria: A Common Factor in Human Diseases
Rizzatti, G., Lopetuso, L. R., Gibiino, G., Binda, C., & Gasbarrini, A. (2017) · BioMed Research International · doi:10.1155/2017/9351507 · Cited by 1,251
“As for asthma, various studies found an increase in Proteobacteria in patients with COPD [80] and, in particular, in patients with exacerbations of disease [81].”
ResultInfluentialBassis, C. M., Erb-Downward, J. R., Dickson, R. P., Freeman, C. M., Schmidt, T. M., Young, V. B., Beck, J. M., Curtis, J. L., & Huffnagle, G. B. (2015) · mBio · doi:10.1128/mbio.00037-15 · Cited by 839
Segal, L. N., Clemente, J. C., Tsay, J.-C. J., Koralov, S. B., Keller, B. C., Wu, B. G., Li, Y., Shen, N., Ghedin, E., Morris, A., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.31 · Cited by 685
The Gut–Lung Axis in Respiratory Disease
Marsland, B. J., Trompette, A., & Gollwitzer, E. S. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201503-133aw · Cited by 630
Lung microbiota promotes tolerance to allergens in neonates via PD-L1
Gollwitzer, E. S., Saglani, S., Trompette, A., Yadava, K., Sherburn, R., McCoy, K. D., Nicod, L. P., Lloyd, C. M., & Marsland, B. J. (2014) · Nature Medicine · doi:10.1038/nm.3568 · Cited by 596
Biomarker development in the precision medicine era: lung cancer as a case study
Vargas, A. J., & Harris, C. C. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.56 · Cited by 556
The dynamic lung microbiome in health and disease
Natalini, J. G., Singh, S., & Segal, L. N. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00821-x · Cited by 523
The role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495
Segal, L. N., Alekseyenko, A. V., Clemente, J. C., Kulkarni, R., Wu, B., Chen, H., Berger, K. I., Goldring, R. M., Rom, W. N., Blaser, M. J., et al. (2013) · Microbiome · doi:10.1186/2049-2618-1-19 · Cited by 482
Lung microbiome: new insights into the pathogenesis of respiratory diseases
Li, R., Li, J., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01722-y · Cited by 434
“29 Not only are the survival and prognosis of patients with COPD related to lung microorganisms, 30 but pneumonia 31 and bronchial diseases 32,33 also involve an imbalance in pulmonary microorganisms.”
BackgroundInteraction between the microbiome and TP53 in human lung cancer
Greathouse, K. L., White, J. R., Vargas, A. J., Bliskovsky, V. V., Beck, J. A., von Muhlinen, N., Polley, E. C., Bowman, E. D., Khan, M. A., Robles, A. I., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1501-6 · Cited by 446
The role of the lung microbiota and the gut–lung axis in respiratory infectious diseases
Dumas, A., Bernard, L., Poquet, Y., Lugo-Villarino, G., & Neyrolles, O. (2018) · Cellular Microbiology · doi:10.1111/cmi.12966 · Cited by 444
“Since 2010, studies have described alterations of the lung microbiota in a number of disease conditions, such as chronic obstructive pulmonary disease, cystic fibrosis, and asthma (Hilty et al., 2010; Pragman et al., 2012; Willner et al., 2012), indicating that the lung microbiota influences both respiratory health an…”
BackgroundBowerman, K. L., Rehman, S. F., Vaughan, A., Lachner, N., Budden, K. F., Kim, R. Y., Wood, D. L. A., Gellatly, S. L., Shukla, S. D., Wood, L. G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19701-0 · Cited by 425
The role of the bacterial microbiome in lung disease
Dickson, R. P., Erb-Downward, J. R., & Huffnagle, G. B. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/ers.13.24 · Cited by 419
A comprehensive repertoire of prokaryotic species identified in human beings
Hugon, P., Dufour, J.-C., Colson, P., Fournier, P.-E., Sallah, K., & Raoult, D. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00293-5 · Cited by 403
Yu, G., Gail, M. H., Consonni, D., Carugno, M., Humphrys, M., Pesatori, A. C., Caporaso, N. E., Goedert, J. J., Ravel, J., & Landi, M. T. (2016) · Genome Biology · doi:10.1186/s13059-016-1021-1 · Cited by 405
“To our knowledge, only one BAL-based study reported the presence of high relative abundance of Thermi (Thermus, ~96 %) in one healthy subject [24].”
BackgroundMacLeod, M., Papi, A., Contoli, M., Beghé, B., Celli, B. R., Wedzicha, J. A., & Fabbri, L. M. (2021) · Respirology · doi:10.1111/resp.14041 · Cited by 359
“There is a substantial variation in the taxonomic composition of the microbiota between healthy individuals, smokers and COPD patients (mainly characterized by the Proteobacteria and Firmicutes phyla).(28,29) Moreover, changes in the lung microbiome are associated with COPD exacerbation events and are potentially impl…”
BackgroundHost–microorganism interactions in lung diseases
Marsland, B. J., & Gollwitzer, E. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3769 · Cited by 351
Dickson, R. P., Erb-Downward, J. R., & Huffnagle, G. B. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70028-1 · Cited by 371
The Effects of Airway Microbiome on Corticosteroid Responsiveness in Asthma
Goleva, E., Jackson, L. P., Harris, J. K., Robertson, C. E., Sutherland, E. R., Hall, C. F., Good, J. T., Gelfand, E. W., Martin, R. J., & Leung, D. Y. M. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0775oc · Cited by 363
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
O’Dwyer, D. N., Dickson, R. P., & Moore, B. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600279 · Cited by 362
Lee, S. H., Sung, J. Y., Yong, D., Chun, J., Kim, S. Y., Song, J. H., Chung, K. S., Kim, E. Y., Jung, J. Y., Kang, Y. A., et al. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.10.016 · Cited by 354
Smoking and microbiome in oral, airway, gut and some systemic diseases
Huang, C., & Shi, G. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1971-7 · Cited by 288
“, once described the lung microbiome in moderate and severe COPD patients, with the former dominated by Actinobacteria and Proteobacteria, the later by Actinobacteria and Firmicutes, and they also found a trend without significant difference that severe subjects contained more Firmicutes and less Actinobacteria and Pr…”
BackgroundAirway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease
Huang, Y. J., Sethi, S., Murphy, T., Nariya, S., Boushey, H. A., & Lynch, S. V. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00035-14 · Cited by 323
Gut-Lung Axis: The Microbial Contributions and Clinical Implications
He, Y., Wen, Q., Yao, F., Xu, D., Huang, Y., & Wang, J. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2016.1176988 · Cited by 301
“The bacterial communities in lungs with COPD are distinct from those of normal controls, although there is no significant difference related to disease severity (Miravitlles & Anzueto, 2015; Pragman et al., 2012).”
BackgroundMayhew, D., Devos, N., Lambert, C., Brown, J. R., Clarke, S. C., Kim, V. L., Magid-Slav, M., Miller, B. E., Ostridge, K. K., Patel, R., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-210408 · Cited by 285
Microbiome effects on immunity, health and disease in the lung
Shukla, S. D., Budden, K. F., Neal, R., & Hansbro, P. M. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.6 · Cited by 287
Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer
Bingula, R., Filaire, M., Radosevic-Robin, N., Bey, M., Berthon, J.-Y., Bernalier-Donadille, A., Vasson, M.-P., & Filaire, E. (2017) · Journal of Oncology · doi:10.1155/2017/5035371 · Cited by 270
Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease
Sze, M. A., Dimitriu, P. A., Suzuki, M., McDonough, J. E., Campbell, J. D., Brothers, J. F., Erb-Downward, J. R., Huffnagle, G. B., Hayashi, S., Elliott, W. M., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0223oc · Cited by 254
Interplay between the lung microbiome and lung cancer
Mao, Q., Jiang, F., Yin, R., Wang, J., Xia, W., Dong, G., Ma, W., Yang, Y., Xu, L., & Hu, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.11.036 · Cited by 254
The human microbiome in disease and pathology
Manos, J. (2022) · APMIS · doi:10.1111/apm.13225 · Cited by 220
“A study of changes in microbiota in patients undergoing treatment for a treatable form of PDIS (Refractory PDIS) showed that successful treatment resulted in a significant reduction in numbers of Porphyromonas endodontalis, Porphyromonas gingivalis, Prevotella spp., Tannerella forsythia, Dialister spp., Selenomonas sp…”
BackgroundInfluentialThe microbiome in respiratory medicine: current challenges and future perspectives
Faner, R., Sibila, O., Agustí, A., Bernasconi, E., Chalmers, J. D., Huffnagle, G. B., Manichanh, C., Molyneaux, P. L., Paredes, R., Pérez Brocal, V., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02086-2016 · Cited by 247
Inflammation and Immune Response in COPD: Where Do We Stand?
Rovina, N., Koutsoukou, A., & Koulouris, N. G. (2013) · Mediators of Inflammation · doi:10.1155/2013/413735 · Cited by 222
Liu, H., Tao, L., Zhang, J., Zhu, Y., Zheng, Y., Liu, D., Zhou, M., Ke, H., Shi, M., & Qu, J. (2018) · International Journal of Cancer · doi:10.1002/ijc.31098 · Cited by 235
Severity-Related Changes of Bronchial Microbiome in Chronic Obstructive Pulmonary Disease
Garcia-Nuñez, M., Millares, L., Pomares, X., Ferrari, R., Pérez-Brocal, V., Gallego, M., Espasa, M., Moya, A., & Monsó, E. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01967-14 · Cited by 229
“Our results do not correlate with previous data from Pragman and colleagues (28), who did not find severity-related differences in the microbial diversity of the bronchial tree in COPD, a discrepancy probably attributable to patient selection and sampling.”
ResultCelli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agustí, A., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0044st · Cited by 220
“Such processes may include genetic and epigenetically determined responses (75, 76), an imbalance of proteinases and antiproteinases (76), an abnormal interaction between environment and microbiome (76), alteration of the microbiome (77), a chronic immune response (78), inappropriate control of programmed cell death (…”
BackgroundNovel aspects of pathogenesis and regeneration mechanisms in COPD
Aldonyte, R., Bagdonas, E., Raudoniute, J., & Bruzauskaite, I. (2015) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s82518 · Cited by 212
“141,149,150 Their main findings suggest that patients with COPD have distinct microbiome in comparison with healthy individuals with the higher prevalence of Afipia, Brevundimonas, Curvibacter, Moraxella, Neisseria, Undibac-terium, Corynebacterium, Capnocytophaga, and Leptolyn-gbya genera.”
The Role of Oral Microbiome in Respiratory Health and Diseases
Pathak, J. L., Yan, Y., Zhang, Q., Wang, L., & Ge, L. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106475 · Cited by 228
Einarsson, G. G., Comer, D. M., McIlreavey, L., Parkhill, J., Ennis, M., Tunney, M. M., & Elborn, J. S. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207235 · Cited by 213
The lung microbiota in early rheumatoid arthritis and autoimmunity
Scher, J. U., Joshua, V., Artacho, A., Abdollahi-Roodsaz, S., Öckinger, J., Kullberg, S., Sköld, M., Eklund, A., Grunewald, J., Clemente, J. C., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0206-x · Cited by 208
“Importantly, however, RA patients were enrolled early in the disease process, therefore minimizing the confounding effects of prolonged inflammatory states and/or immunomodulatory therapeutic consequences on the microbiome [24].”
Airway dysbiosis:Haemophilus influenzae and Tropheryma in poorly controlled asthma
Simpson, J. L., Daly, J., Baines, K. J., Yang, I. A., Upham, J. W., Reynolds, P. N., Hodge, S., James, A. L., Hugenholtz, P., Willner, D., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00405-2015 · Cited by 204
Celli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agustí, A., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00009015 · Cited by 204
The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD
Leung, J. M., Tiew, P. Y., Mac Aogáin, M., Budden, K. F., Yong, V. F. L., Thomas, S. S., Pethe, K., Hansbro, P. M., & Chotirmall, S. H. (2017) · Respirology · doi:10.1111/resp.13032 · Cited by 196
Respiratory microbiome and epithelial interactions shape immunity in the lungs
Invernizzi, R., Lloyd, C. M., & Molyneaux, P. L. (2020) · Immunology · doi:10.1111/imm.13195 · Cited by 193
The Human Respiratory System and its Microbiome at a Glimpse
Santacroce, L., Charitos, I. A., Ballini, A., Inchingolo, F., Luperto, P., De Nitto, E., & Topi, S. (2020) · Biology · doi:10.3390/biology9100318 · Cited by 183
Methods in Lung Microbiome Research
Carney, S. M., Clemente, J. C., Cox, M. J., Dickson, R. P., Huang, Y. J., Kitsios, G. D., Kloepfer, K. M., Leung, J. M., LeVan, T. D., Molyneaux, P. L., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0273tr · Cited by 184
Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes
Zhang, Q., Cox, M., Liang, Z., Brinkmann, F., Cardenas, P. A., Duff, R., Bhavsar, P., Cookson, W., Moffatt, M., & Chung, K. F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152724 · Cited by 193
“On the other hand, in the small study of the lung microbiome in patients with moderate to severe COPD, the alterations in lung microbiome reported may have been accounted for by inhaled corticosteroid therapy [41].”
BackgroundChronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis
Parris, B. A., O’Farrell, H. E., Fong, K. M., & Yang, I. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.10.54 · Cited by 194
“(158), however, the majority of other studies have concluded that the Firmicutes phylum is the most common in both moderate and severe COPD (159,160).”
ResultThe path to personalised medicine in COPD
Agusti, A. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205507 · Cited by 195
Sommariva, M., Le Noci, V., Bianchi, F., Camelliti, S., Balsari, A., Tagliabue, E., & Sfondrini, L. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03452-8 · Cited by 178
The Lung Microbiome during Health and Disease
Yagi, K., Huffnagle, G. B., Lukacs, N. W., & Asai, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910872 · Cited by 179
Adiponectin in inflammatory and immune-mediated diseases
Fantuzzi, G. (2013) · Cytokine · doi:10.1016/j.cyto.2013.06.317 · Cited by 171
Cameron, S. J. S., Lewis, K. E., Huws, S. A., Hegarty, M. J., Lewis, P. D., Pachebat, J. A., & Mur, L. A. J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177062 · Cited by 182
“A history of previous lung disease such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, tuberculosis and pneumonia has been associated with an increased risk of developing lung cancer [6].”
BackgroundInfluentialLong-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD
Contoli, M., Pauletti, A., Rossi, M. R., Spanevello, A., Casolari, P., Marcellini, A., Forini, G., Gnesini, G., Marku, B., Barnes, N., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00451-2017 · Cited by 169
Airway host-microbiome interactions in chronic obstructive pulmonary disease
Wang, Z., Maschera, B., Lea, S., Kolsum, U., Michalovich, D., Horn, S. V., Traini, C., Brown, J. R., Hessel, E. M., & Singh, D. (2019) · Respiratory Research · doi:10.1186/s12931-019-1085-z · Cited by 172
Lung Microbiome for Clinicians. New Discoveries about Bugs in Healthy and Diseased Lungs
Segal, L. N., Rom, W. N., & Weiden, M. D. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201310-339fr · Cited by 169
Brandenberger, C., & Mühlfeld, C. (2017) · Cell and Tissue Research · doi:10.1007/s00441-016-2511-x · Cited by 152
The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease
Pragman, A. A., Lyu, T., Baller, J. A., Gould, T. J., Kelly, R. F., Reilly, C. S., Isaacson, R. E., & Wendt, C. H. (2018) · Microbiome · doi:10.1186/s40168-017-0381-4 · Cited by 150
“Our study of the lung microbiota in COPD also found oral taxa in the lung [1].”
BackgroundMethodInfluentialSelf-citationMulticenter comparison of lung and oral microbiomes of HIV-infected and HIV-uninfected individuals.
Beck, J. M., Schloss, P. D., Venkataraman, A., Twigg, H., Jablonski, K. A., Bushman, F. D., Campbell, T. B., Charlson, E. S., Collman, R. G., Crothers, K., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0128oc · Cited by 150
“Our BAL results agree closely with published data obtained from subjects without respiratory disease and further support the current consensus regarding communities of bacteria identified in the lungs (6, 10, 13, 15, 34).”
ResultSeed, P. C. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019810 · Cited by 145
“Even the lower respiratory tract has a complex dynamic microbiome that is altered during diseases, such as cystic fibrosis and chronic obstructive pulmonary disease (Pragman et al. 2012).”
BackgroundWang, Z., Singh, R., Miller, B. E., Tal‐Singer, R., Horn, S. V., Tomsho, L., Mackay, A. J., Allinson, J. P., Webb, A. J., Brookes, A. J., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210741 · Cited by 158
Filho, F. S. L., Alotaibi, N. M., Ngan, D., Tam, S., Yang, J., Hollander, Z., Chen, V., FitzGerald, J. M., Nislow, C., Leung, J. M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1135oc · Cited by 149
Chang, X., Zhou, S., Yan, Z., Zhang, Q., Liu, J., Wang, Y., Guan, X., Wu, Q., & Liu, R. (2025) · Phytotherapy Research · doi:10.1002/ptr.70008 · Cited by 146
“…groups exhibit distinct microbial profiles compared to healthy individuals, marked by increased Firmicutes and Neisseria abundance, reduced Proteobacteria levels, and heterogeneity between sputum and bronchoalveolar lavage microbiomes (Morris et al. 2013; Sze et al. 2012; Pragman et al. 2012).”
Biomarkers of progression of chronic obstructive pulmonary disease (COPD).
Shaw, J. G., Vaughan, A., Dent, A. G., O’Hare, P. E., Goh, F., Bowman, R., Fong, K. M., & Yang, I. A. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.11.33 · Cited by 157
“In COPD, bacterial community profiles in BAL samples from patients using inhaled steroids and long-acting bronchodilators clustered differently from the profiles observed in patients not using these medications (105).”
Wu, B. G., Sulaiman, I., Tsay, J.-C. J., Perez, L., Franca, B., Li, Y., Wang, J., Gonzalez, A. N., El-Ashmawy, M., Carpenito, J., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-1596oc · Cited by 146
Whiteson, K. L., Bailey, B., Bergkessel, M., Conrad, D., Delhaes, L., Felts, B., Harris, J. K., Hunter, R., Lim, Y. W., Maughan, H., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2129pp · Cited by 123
Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
Restrepo, M. I., Sibila, O., & Anzueto, A. (2018) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2018.0030 · Cited by 152
Bacterial microbiome of lungs in COPD
Sin, D., Sze, M., & Hogg, J. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s38932 · Cited by 121
“It should also be noted that the concept of reduced diversity with disease progression has not been consistently replicated, even in studies using BAL samples.(18) In contrast”
BackgroundResultInfluentialMicrobiomes in respiratory health and disease: An Asia‐Pacific perspective
Chotirmall, S. H., Gellatly, S. L., Budden, K. F., Aogáin, M. M., Shukla, S. D., Wood, D., Hugenholtz, P., Pethe, K., & Hansbro, P. M. (2017) · Respirology · doi:10.1111/resp.12971 · Cited by 127
Iron at the Centre of Candida albicans Interactions
Fourie, R., Kuloyo, O. O., Mochochoko, B. M., Albertyn, J., & Pohl, C. H. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00185 · Cited by 118
Impaired macrophage phagocytosis of bacteria in severe asthma
Liang, Z., Zhang, Q., Thomas, C. M. R., Chana, K. K., Gibeon, D. S., Barnes, P. J., Chung, K. F., Bhavsar, P. K., & Donnelly, L. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-72 · Cited by 115
Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle
García-Castillo, V., Sanhueza, E., McNerney, E. M., Oñate, S. A., & García, A. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000371 · Cited by 125
“Chronic obstructive pulmonary disease (COPD) is defined as the obstruction in the flow of air (Pragman et al., 2012).”
Evaluation of the airway microbiome in nontuberculous mycobacteria disease
Sulaiman, I., Wu, B. G., Li, Y., Scott, A. S., Malecha, P. W., Scaglione, B. D., Wang, J., Basavaraj, A., Chung, S., Bantis, K., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00810-2018 · Cited by 121
The sputum microbiome is distinct between COPD and health, independent of smoking history
Haldar, K., George, L., Wang, Z., Mistry, V., Ramsheh, M. Y., Free, R. C., John, C., Reeve, N. F., Miller, B. E., Tal‐Singer, R., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01448-3 · Cited by 116
Microbial communities in the respiratory tract of patients with interstitial lung disease
Garzoni, C., Brugger, S. D., Qi, W., Wasmer, S., Cusini, A., Dumont, P., Gorgievski-Hrisoho, M., Mühlemann, K., von Garnier, C., & Hilty, M. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202917 · Cited by 105
Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications
Khatiwada, S., & Subedi, A. (2020) · Human Microbiome Journal · doi:10.1016/j.humic.2020.100073 · Cited by 109
“In another common lung disease, chronic obstructive pulmonary disease (COPD), Lactobacillus, Fusobacteria, Leptotrichia and Fusobacterium were observed in abundant numbers [26,27].”
Madapoosi, S., Cruickshank-Quinn, C. I., Opron, K., Erb‐Downward, J. R., Begley, L., Li, G., Barjaktarević, I., Barr, R. G., Comellas, A. P., Couper, D. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202110-2241oc · Cited by 110
Microbiota abnormalities in inflammatory airway diseases — Potential for therapy
Gollwitzer, E. S., & Marsland, B. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.08.002 · Cited by 100
“Pragman et al. (2012) showed that there is an increase in bacterial diversity in COPD patients, however, this increase is not related to disease severity.”
BackgroundBrassington, K., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Clinical Science · doi:10.1042/cs20180316 · Cited by 111
Chen, C., Wang, Z., Wang, J., Ding, C., Sun, C., Liu, P., Xu, X., Liu, Y., Chen, B., & Gu, B. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-19-590 · Cited by 105
“A significant increase in TM7 was also observed in COPD patients compared with the healthy controls, indicating that TM7 may play an essential role in COPD and lung cancer patients (32).”
Wang, Z., Yang, Y., Yan, Z., Liu, H., Chen, B., Liang, Z., Wang, F., Miller, B. E., Tal‐Singer, R., Yi, X., et al. (2020) · The ISME Journal · doi:10.1038/s41396-020-0727-y · Cited by 102
“Increasing evidence suggests that airway microbial communities differ between health and COPD [3, 4], shift during episodes of disease exacerbations [5–7] and associate with airway inflammation [6].”
BackgroundGong, H.-L., Shi, Y., Zhou, L., Wu, C.-P., Cao, P.-Y., Tao, L., Xu, C., Hou, D.-S., & Wang, Y.-Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066476 · Cited by 96
The Lung Microbiome and Its Role in Pneumonia
Wu, B. G., & Segal, L. N. (2018) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2018.07.003 · Cited by 103
Lung tissue microbial profile in lung cancer is distinct from emphysema.
Liu, Y., O’Brien, J. L., Ajami, N. J., Scheurer, M. E., Amirian, E. S., Armstrong, G., Tsavachidis, S., Thrift, A. P., Jiao, L., Wong, M. C., et al. (2018) · Europe PMC (PubMed Central) · Cited by 107
Sze, M. A., Abbasi, M., Hogg, J. C., & Sin, D. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110351 · Cited by 91
“bacterial microbiome between normal lungs and COPD lungs that might affect disease pathogenesis and progression [19,21].”
BackgroundMethodHealy, C., Munoz-Wolf, N., Strydom, J., Faherty, L., Williams, N. C., Kenny, S., Donnelly, S. C., & Cloonan, S. M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01722-y · Cited by 78
Ren, L., Zhang, R., Rao, J. Y., Xiao, Y., Zhang, Z., Yang, B., Cao, D., Zhong, H., Ning, P., Shang, Y., et al. (2018) · mSystems · doi:10.1128/msystems.00199-18 · Cited by 96
“Such clearance is impaired in COPD patients (20, 31), and therefore enrichment of UO microbes is likely to be a FIG 6 Enrichment of KEGG pathways in microbial genes in different samples.”
BackgroundHost genetic variation in mucosal immunity pathways influences the upper airway microbiome
Igartua, C., Davenport, E. R., Gilad, Y., Nicolae, D. L., Pinto, J., & Ober, C. (2017) · Microbiome · doi:10.1186/s40168-016-0227-5 · Cited by 83
Longitudinal analysis of the lung microbiome in lung transplantation
Borewicz, K., Pragman, A. A., Kim, H. B., Hertz, M., Wendt, C., & Isaacson, R. E. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12053 · Cited by 86
“Our study included 12 patient samples (four patients at three time points) from individuals transplanted due to COPD.”
BackgroundResultSelf-citationLung inflammation and disease: A perspective on microbial homeostasis and metabolism
Méndez, R., Banerjee, S., Bhattacharya, S. K., & Banerjee, S. (2018) · IUBMB Life · doi:10.1002/iub.1969 · Cited by 95
“(ii) Bacteroidetes and Proteobacteria dominated (lung tissue-derived) (22) and (iii) Diverse/no dominance (BAL-derived) (10, 21).”
BackgroundGupta, S., Shariff, M., Chaturvedi, G., Sharma, A., Goel, N., Yadav, M., Mortensen, M. S., Sørensen, S. J., Mukerji, M., & Chauhan, N. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-83524-2 · Cited by 84
Facciponte, D. N., Bough, M. W., Seidler, D., Carroll, J. L., Ashare, A., Andrew, A. S., Tsongalis, G. J., Vaickus, L. J., Henegan, P. L., Butt, T. H., et al. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.07.226 · Cited by 81
“Study participants included 19 healthy controls, 8 individuals with Cystic Fibrosis (CF), 1 individual with pulmonary lung nodules and asthma, and 1 participant with Chronic Obstructive Pulmonary Disease (COPD).”
BackgroundInfluentialHuang, Y. J., Erb‐Downward, J. R., Dickson, R. P., Curtis, J. L., Huffnagle, G. B., & Han, M. K. (2016) · Translational research · doi:10.1016/j.trsl.2016.06.007 · Cited by 90
Manavathu, E. K., Vager, D. L., & Vazquez, J. A. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-53 · Cited by 80
Yang, X., Li, H., Ma, Q., Zhang, Q., & Wang, C. (2018) · BioMed Research International · doi:10.1155/2018/9230234 · Cited by 80
“Third, corticosteroid therapy may affect the levels of neutrophils in airways and may even lead to alterations in airway and lung microbiome [35, 36].”
BackgroundThe airway microbiome in COPD, bronchiectasis and bronchiectasis‐COPD overlap
Tiew, P. Y., Jaggi, T. K., Chan, L., & Chotirmall, S. H. (2020) · The Clinical Respiratory Journal · doi:10.1111/crj.13294 · Cited by 96
Toma, I., Siegel, M., Keiser, J. F., Yakovleva, A., Kim, A., Davenport, L., Devaney, J., Hoffman, E. P., Alsubail, R., Crandall, K. A., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01678-14 · Cited by 78
“Furthermore, as is often the case, these ICU patients had other medical complications, including asthma, emphysema, and chronic obstructive pulmonary disease (COPD), which prior studies have established as factors associated with microbiome changes (22, 46).”
MethodInhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease
Finney, L., Berry, M. P. R., Singanayagam, A., Elkin, S., Johnston, S. L., & Mallia, P. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70169-9 · Cited by 84
Metadata
- Authors
- Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C., & Isaacson, R. E.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Isaacson, Richard E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-10-11
- Volume
- 7
- Issue
- 10
- Pages
- e47305
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3469539
- OpenAlex
- W2077691383
- Cited by
- 437
- References
- 42
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 29 · 2023: 20 · 2022: 37 · 2021: 50 · 2020: 39 · 2019: 26 · 2018: 38 · 2017: 34 · 2016: 37 · 2015: 28 · 2014: 39 · 2013: 20 · 2012: 2
- FWCI
- 22.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Minnesota
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
- National Institutes of Health (n01hr096140-001)
- University of Illinois at Urbana-Champaign
- National Heart, Lung, and Blood Institute (N01 HR096140, N010HR-96140)
- National Institute of Allergy and Infectious Diseases (T32AI55433, T32AI055433)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- lung microbiome, chronic obstructive pulmonary disease, COPD exacerbations, bronchoalveolar lavage fluid, microbial diversity, oral bacteria, inhaled corticosteroids, inhaled bronchodilators, disease severity, actinobacteria, Firmicutes, Proteobacteria
- MeSH terms
- Adult, Aged, Bronchoalveolar Lavage Fluid, Chronic Disease, Female, Humans, Lung, Male, Middle Aged, RNA, Ribosomal, 16S, Proteobacteria, Pulmonary Disease, Chronic Obstructive, Actinobacteria, Bacteroidetes, Fusobacteria, Metagenome, Acidobacteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.